Seven Eight Capital’s BeOne Medicines Ltd ONC Stock Holding History

Seven Eight Capital’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,246	Closed	-$269K	–	682
2023 Q1	$269K	Buy	+1,246	New	+$299K	0.06%	351
2021 Q2	–	Sell	-2,100	Closed	-$543K	–	734
2021 Q1	$543K	Hold	2,100	–	–	0.12%	252
2020 Q4	$543K	Buy	+2,100	New	+$578K	0.12%	255
2020 Q1	–	Sell	-1,983	Closed	-$329K	–	751
2019 Q4	$329K	Buy	+1,983	New	+$329K	0.02%	571
2018 Q3	–	Sell	-6,700	Closed	-$1.03M	–	730
2018 Q2	$1.03M	Buy	+6,700	New	+$1.19M	0.07%	282

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Seven Eight Capital's ONC Position: Q2 2023 in Review

Seven Eight Capital sold out of BeOne Medicines Ltd (ONC) in Q2 2023, closing a stake of 1,246 shares — an estimated $269K sold.

Seven Eight Capital first reported a position in ONC in Q2 2018 and held it in 5 quarters. The position peaked at $1.03M in Q2 2018. 208 funds tracked by Wall St. Rank hold ONC as of Q2 2023.

Seven Eight Capital reported no remaining BeOne Medicines Ltd position as of Q2 2023 after selling out during the quarter.
Seven Eight Capital sold 1,246 BeOne Medicines Ltd shares in Q2 2023, an estimated $269K.
Seven Eight Capital first reported a position in BeOne Medicines Ltd in Q2 2018 and held it in 5 quarters.
Seven Eight Capital's BeOne Medicines Ltd position peaked at $1.03M in Q2 2018.
208 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2023.

Based on Seven Eight Capital's 13F filing for Q2 2023, filed 14 Aug 2023.